相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Use of Matched Unrelated Donors Compared with Matched Related Donors Is Associated with Lower Relapse and Superior Progression-Free Survival after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation
Vincent T. Ho et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
HLA-Allele Matched Unrelated Donors Compared to HLA-Matched Sibling Donors: Role of Cell Source and Disease Risk Category
Ann Woolfrey et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation
S. Pallua et al.
BONE MARROW TRANSPLANTATION (2010)
Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia
ZiYi Lim et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prospective Evaluation of Allogeneic Hematopoietic Stem-Cell Transplantation From Matched Related and Matched Unrelated Donors in Younger Adults With High-Risk Acute Myeloid Leukemia: German-Austrian Trial AMLHD98A
Richard F. Schlenk et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Sibling versus Unrelated Donor Allogeneic Hematopoietic Cell Transplantation for Chronic Myelogenous Leukemia: Refined HLA Matching Reveals More Graft-versus-Host Disease but not Less Relapse
Daniel J. Weisdorf et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation
Olle Ringden et al.
BLOOD (2009)
Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission Systematic Review and Meta-analysis of Prospective Clinical Trials
John Koreth et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
HLA-Identical Sibling Compared With 8/8 Matched and Mismatched Unrelated Donor Bone Marrow Transplant for Chronic Phase Chronic Myeloid Leukemia
Mukta Arora et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study
B-S Cho et al.
LEUKEMIA (2009)
Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission
N. Basara et al.
LEUKEMIA (2009)
Reduced-intensity conditioning follow by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders
Ginna G. Laport et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program
Chatchada Karanes et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning
Mohamed L. Sorror et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome
M. de Lima et al.
LEUKEMIA (2008)
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation
Stephanie J. Lee et al.
BLOOD (2007)
A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model
Xu Zhang et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2007)
Comorbidity and disease status-based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation
Mohamed L. Sorror et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma
John Kuruvilla et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?
Jan J. Cornelissen et al.
BLOOD (2007)
Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation
Corey Cutler et al.
BLOOD (2007)
Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy:: A prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy
Ibrahim Yakoub-Agha et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia
Jennifer R. Brown et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide
Christopber L. Hallemeier et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission - A metaanalysis
M Yanada et al.
CANCER (2005)
Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CRI): an intention-to-treat analysis of the EORTC/GIMEMA AML-10 trial
S Suciu et al.
BLOOD (2003)
Hematopoietic stem cell transplantation:: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors
HD Ottinger et al.
BLOOD (2003)
Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?
SS Grewal et al.
BLOOD (2003)
Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation
DJ Weisdorf et al.
BLOOD (2002)
Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation
EP Alyea et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Science, medicine, and the future - Stem cell transplantation
AL Lennard et al.
BRITISH MEDICAL JOURNAL (2000)
Predicting costs of stem-cell transplantation
SJ Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
